Alpha Teknova, Inc. (NASDAQ:TKNO - Get Free Report) reached a new 52-week high on Tuesday . The company traded as high as $9.72 and last traded at $9.45, with a volume of 208104 shares. The stock had previously closed at $7.68.
Alpha Teknova Stock Up 12.0 %
The company has a market cap of $458.45 million, a price-to-earnings ratio of -11.62 and a beta of 0.37. The business has a fifty day moving average of $7.18 and a two-hundred day moving average of $4.76. The company has a current ratio of 4.73, a quick ratio of 3.94 and a debt-to-equity ratio of 0.12.
Alpha Teknova (NASDAQ:TKNO - Get Free Report) last announced its earnings results on Thursday, November 7th. The company reported ($0.15) earnings per share for the quarter, missing the consensus estimate of ($0.11) by ($0.04). Alpha Teknova had a negative return on equity of 35.30% and a negative net margin of 87.17%. The business had revenue of $9.58 million for the quarter, compared to analyst estimates of $9.30 million. During the same period in the previous year, the company earned ($0.34) earnings per share. As a group, equities analysts anticipate that Alpha Teknova, Inc. will post -0.58 EPS for the current fiscal year.
Institutional Trading of Alpha Teknova
A number of institutional investors and hedge funds have recently modified their holdings of the stock. State Street Corp increased its position in shares of Alpha Teknova by 249.3% during the third quarter. State Street Corp now owns 76,645 shares of the company's stock worth $371,000 after purchasing an additional 54,700 shares in the last quarter. Geode Capital Management LLC grew its holdings in shares of Alpha Teknova by 24.4% during the third quarter. Geode Capital Management LLC now owns 188,173 shares of the company's stock worth $911,000 after buying an additional 36,914 shares in the last quarter. Point72 Asset Management L.P. acquired a new stake in shares of Alpha Teknova in the third quarter valued at about $1,483,000. Finally, Roubaix Capital LLC acquired a new stake in shares of Alpha Teknova in the third quarter valued at about $2,015,000. Hedge funds and other institutional investors own 13.81% of the company's stock.
About Alpha Teknova
(
Get Free Report)
Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.
Further Reading
Before you consider Alpha Teknova, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Alpha Teknova wasn't on the list.
While Alpha Teknova currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
